Related Experiment Video
Updated: Dec 16, 2025

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery
Published on: May 30, 2025
Advances of epigenetic editing.
Rutger A F Gjaltema1, Marianne G Rots2
1Otto-Warburg-Laboratory, Max Planck Institute for Molecular Genetics, Berlin, Germany.
Epigenetic editing uses CRISPR-dCas9 technology to precisely alter gene expression. This review highlights its applications in mammals and biochemical advancements for versatile therapeutic uses.
Area of Science:
- Molecular Biology
- Genetics
- Epigenetics
Background:
- Epigenetic editing precisely targets genomic sites to modify the local epigenetic landscape.
- CRISPR-dCas9 systems have significantly advanced epigenetic editing technologies.
- These tools have shown promise in preclinical therapeutic applications.
Purpose of the Study:
- To review current applications of epigenetic editing tools in mammals.
- To discuss biochemical improvements enhancing the versatility of these tools.
- To provide insights into future directions for epigenetic editing.
Main Methods:
- Review of existing literature on epigenetic editing.
- Analysis of CRISPR-dCas9 based systems for locus-specific epigenetic modification.
- Examination of various epigenetic enzymes used in editing strategies.
Main Results:
- Epigenetic editing tools, particularly CRISPR-dCas9, are widely applied in mammalian systems.
- Significant preclinical therapeutic successes have been achieved.
- Biochemical refinements are expanding the scope and precision of these tools.
Conclusions:
- Epigenetic editing offers a powerful approach for transcriptional reprogramming.
- Ongoing advancements in biochemical strategies are crucial for broadening therapeutic potential.
- Further research will likely uncover novel applications in disease treatment and biological research.
More Related Videos
10:44In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
CRISPR
RNA Editing
CRISPR/Cas9 Genome Editing
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...